IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) has become a common chronic liver disease in the world. Simple steatosis (SS) is the early phase of NAFLD. However, the molecular mechanisms underlying the development of steatosis have not yet been fully elucidated. METHODS: Two public...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xu, Tang, Yi, Chen, Shen, Ling, Wenhua, Wang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562889/
https://www.ncbi.nlm.nih.gov/pubmed/34524971
http://dx.doi.org/10.1530/EC-21-0353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562889/
https://www.ncbi.nlm.nih.gov/pubmed/34524971
http://dx.doi.org/10.1530/EC-21-0353

Ejemplares similares